Tectonic Therapeutic | AVRO - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Alnylam Pharmaceuticals USD 221.65M 60.52M 2026-03
Celltrion KRW 11.84B 1.34B 2026-03
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Dianthus Therapeutics USD -40.83M 23.6M 2026-03
Divis Laboratories Ltd INR 9.63B 1.09B 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
Ionis Pharmaceuticals USD -93M 135M 2026-03
Kangmei Pharma CNY -14.01M 16.08M 2026-03
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
MacroGenics USD -36.77M 21.84M 2026-03
Medical Developments International AUD -149K 466K 2025-06
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
Organigram Holdings CAD -921K 40.8M 2026-03
Pfizer USD 5.18B 6.82B 2026-03
Pharma Mar EUR 1.6M 38.6M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
Roche Holding CHF 4.79B 3.01B 2025-06
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sanofi EUR -1.16B 5.5B 2025-12
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Sartorius EUR 157.8M 76.1M 2026-03
Takeda JPY -52.48B 186.34B 2026-03
Tilray USD -39.96M 39.19M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 876.07M 352.96M 2026-03